Japan's Tosoh to up pharma intermediate capacity by Mar '03

13 June 2002 04:00  [Source: ICIS news]

SINGAPORE (CNI)—Tosoh Corp will double its hydrophilic gel resin capacity to 50 000 litre/year at its plant in Shinnanyo, Yamaguchi, Japan, by March 2003, a company spokesman told CNI on Thursday.

The Japanese petrochemicals producer will spend Yen500m ($3.97m/Euro4.21m) to expand its facilities for producing hydrophilic gel resin - a pharmaceutical intermediate used to purify and separate biochemicals such as enzymes and antibiotics.

The Tosoh spokesman said that hydrophilic gel resin is sold under the brandname Toyopearl. He added that demand for Toyopearl is growing from pharmaceutical producers.

By: Iqbal Anand
+65 6780 4359

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly